Biologics Market Global Briefing 2018

Starting Price : $ 1000.00 | Pages : 34 | Published : January 2018 | SKU CODE : 2777 | Format :

The biologics industry comprises companies manufacturing biological products that are derived from genetically modified proteins and human genes. Biologics products include a wide range of recombinant therapeutic proteins, gene therapy tissues, somatic cells, vaccines, and allergenics. These products are isolated from natural sources such as human, animal, and microorganisms by biotechnological methods and other cutting-edge technologies.

The global biologics market was valued at around $221 billion in 2017. North America was the largest region in the biologics market in 2017, accounting for nearly 40% market share. The USA was the largest country in the market in 2017, accounting for more than 27% market share.
Biologics are being widely used to provide effective treatment for many complex diseases such as rheumatoid arthritis, psoriasis, and Crohn’s disease that have limited treatment options. There has been a significant advancement for the treatment of rheumatoid arthritis patients who do not respond to traditional disease-modifying anti-rheumatic drugs.

The top five companies covered are Amgen, AbbVie Inc., Johnson & Johnson, Bristol-Myers Squibb Company and Pfizer Inc. Amgen was the largest company in the biologics market in 2017.

The countries covered are USA, China, Germany, Brazil, Japan, UK, Spain, Russia, France, Australia, Italy, India and rest of the world.

The biologics market is segmented into Monoclonal Antibodies (MAbS), Vaccines and Recombinant Hormones/Proteins.
Monoclonal Antibodies (MAbS) are cells derived by cell division from a single ancestral cell. Monoclonal antibodies recognize and bind to antigens in order to discriminate between specific epitopes which provide protection against disease organisms.
Vaccines are biological preparations that provide immunity from a disease. Vaccines can be administered orally, through injections or by aerosol. Vaccines for cancers include both prophylactic vaccines and therapeutic vaccines.
Recombinant Hormones/Proteins are synthetic hormones secreted into the blood cycle to stimulate specific cells or tissues into action.

Opioids and Other Analgesics Are The Fastest-Growing Neurology Drugs

North America`s Cardiovascular Drugs Market To Shrink 5% 2013-21

Biologics Logistics Outsourcing Market Growth Nearly Twice Other Pharma`s

Challenges To Big Pharma Are Helping Drive The Bio-Pharmaceutical Logistics Market

Over 1000 Biologics Under Development Will Drive The Biologics Market To 10% Yearly Growth

Public Policy Restrains Blood Glucose Test Strips Market Growth

The Leading Players In The Cardiovascular Devices Market Are Innovating To Stay Ahead

India Is The World’s Fastest-Growing Market For In-Vitro Diagnostics

Veterinary Services Global Market Report 2018

View Report

Blood Glucose Test Strips Global Market Report 2018

View Report

Nephrology And Urology Devices Market Global Briefing 2018

View Report

Neurology Devices Market Global Briefing 2018

View Report

ENT Devices Market Global Briefing 2018

View Report

Orthopedic Devices Market Global Briefing 2018

View Report

Wound Care Devices Market Global Briefing 2018

View Report

Diabetes Care Devices Market Global Briefing 2018

View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)